Panagora Asset Management Inc. has strengthened its position in Kenvue Inc. by increasing its holdings by 14.5% in the first quarter. This move adds 8,558 shares to the asset manager’s portfolio, bringing its total holdings to 67,617 shares, now valued at $1,621,000.

Panagora Asset Management Inc. recently increased its stake in Kenvue Inc. by 14.5%, adding 8,558 shares to bring its total to 67,617 shares, according to an SEC filing. The move signals continued institutional interest in Kenvue’s NYSE-listed stock.

Baird Financial Group Inc. recently reduced its stake in Kenvue Inc. by 18.1%, selling nearly 156,000 shares in the first quarter. Despite this sale, Baird retains over 700,000 shares, valued at $16.93 million.

Kenvue, the manufacturer of Tylenol, has replaced its CEO amid an ongoing strategic review. The leadership change has prompted reactions from investors, with the company’s stock showing movement in response to the news.